BR9506606A - Método de tratamento de condiçóes ovarianas dependentes de estrogênio - Google Patents

Método de tratamento de condiçóes ovarianas dependentes de estrogênio

Info

Publication number
BR9506606A
BR9506606A BR9506606A BR9506606A BR9506606A BR 9506606 A BR9506606 A BR 9506606A BR 9506606 A BR9506606 A BR 9506606A BR 9506606 A BR9506606 A BR 9506606A BR 9506606 A BR9506606 A BR 9506606A
Authority
BR
Brazil
Prior art keywords
treating estrogen
ovarian conditions
dependent ovarian
dependent
conditions
Prior art date
Application number
BR9506606A
Other languages
English (en)
Portuguese (pt)
Inventor
Gary D Hodgen
Robert F Williams
Daniel Grow
Original Assignee
Hampton Roads Medical College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hampton Roads Medical College filed Critical Hampton Roads Medical College
Publication of BR9506606A publication Critical patent/BR9506606A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
BR9506606A 1994-02-04 1995-02-02 Método de tratamento de condiçóes ovarianas dependentes de estrogênio BR9506606A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/191,631 US5681817A (en) 1994-02-04 1994-02-04 Treatment of ovarian estrogen dependent conditions
PCT/US1995/001479 WO1995020972A1 (en) 1994-02-04 1995-02-02 Treatment of ovarian estrogen dependent conditions

Publications (1)

Publication Number Publication Date
BR9506606A true BR9506606A (pt) 1997-09-09

Family

ID=22706258

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9506606A BR9506606A (pt) 1994-02-04 1995-02-02 Método de tratamento de condiçóes ovarianas dependentes de estrogênio

Country Status (29)

Country Link
US (1) US5681817A (OSRAM)
EP (1) EP0785792B1 (OSRAM)
JP (1) JP3130048B2 (OSRAM)
KR (1) KR970700507A (OSRAM)
CN (1) CN1144486A (OSRAM)
AP (1) AP724A (OSRAM)
AT (1) ATE179610T1 (OSRAM)
AU (1) AU689229B2 (OSRAM)
BG (1) BG62238B1 (OSRAM)
BR (1) BR9506606A (OSRAM)
CA (1) CA2182183C (OSRAM)
CZ (1) CZ291709B6 (OSRAM)
DE (1) DE69509544T2 (OSRAM)
DK (1) DK0785792T3 (OSRAM)
ES (1) ES2132645T3 (OSRAM)
FI (1) FI963036L (OSRAM)
GR (1) GR3030164T3 (OSRAM)
HU (1) HUT74622A (OSRAM)
LT (1) LT4182B (OSRAM)
LV (1) LV11782B (OSRAM)
MD (1) MD1432C2 (OSRAM)
NZ (1) NZ281441A (OSRAM)
OA (1) OA10777A (OSRAM)
PL (1) PL178273B1 (OSRAM)
RO (1) RO117420B1 (OSRAM)
RU (1) RU2110274C1 (OSRAM)
SK (1) SK96296A3 (OSRAM)
TJ (1) TJ242B (OSRAM)
WO (1) WO1995020972A1 (OSRAM)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK282118B6 (sk) * 1994-07-22 2001-11-06 The Medical College Of Hampton Roads Použitie antagonistu hormónu uvoľňujúceho gonadotropíny
US5780435A (en) * 1995-12-15 1998-07-14 Praecis Pharmaceuticals Incorporated Methods for treating prostate cancer with LHRH-R antagonists
CA2306110A1 (en) 1997-10-17 1999-04-29 Mochida Pharmaceutical Co., Ltd. Therapeutic agent of uterine leiomyoma, containing dienogest as effective ingredient
US6703367B1 (en) 1999-04-27 2004-03-09 Praecis Pharmaceuticals Inc. Methods for treating hot flashes and gynaecomastia
US6358948B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
US6380178B1 (en) 1999-05-04 2002-04-30 American Home Products Corporation Cyclic regimens using cyclocarbamate and cyclic amide derivatives
US6380235B1 (en) 1999-05-04 2002-04-30 American Home Products Corporation Benzimidazolones and analogues
US6407101B1 (en) 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
US6306851B1 (en) 1999-05-04 2001-10-23 American Home Products Corporation Cyclocarbamate and cyclic amide derivatives
US6339098B1 (en) 1999-05-04 2002-01-15 American Home Products Corporation 2,1-benzisothiazoline 2,2-dioxides
US6423699B1 (en) 1999-05-04 2002-07-23 American Home Products Corporation Combination therapies using benzimidazolones
US6417214B1 (en) * 1999-05-04 2002-07-09 Wyeth 3,3-substituted indoline derivatives
US6391907B1 (en) * 1999-05-04 2002-05-21 American Home Products Corporation Indoline derivatives
US6329416B1 (en) 1999-05-04 2001-12-11 American Home Products Corporation Combination regimens using 3,3-substituted indoline derivatives
US6319912B1 (en) 1999-05-04 2001-11-20 American Home Products Corporation Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides
US6462032B1 (en) 1999-05-04 2002-10-08 Wyeth Cyclic regimens utilizing indoline derivatives
US6498154B1 (en) 1999-05-04 2002-12-24 Wyeth Cyclic regimens using quinazolinone and benzoxazine derivatives
US6358947B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Tetracyclic progesterone receptor modulator compounds and methods
US6355648B1 (en) 1999-05-04 2002-03-12 American Home Products Corporation Thio-oxindole derivatives
US6509334B1 (en) 1999-05-04 2003-01-21 American Home Products Corporation Cyclocarbamate derivatives as progesterone receptor modulators
US6444668B1 (en) 1999-05-04 2002-09-03 Wyeth Combination regimens using progesterone receptor modulators
US6369056B1 (en) 1999-05-04 2002-04-09 American Home Products Corporation Cyclic urea and cyclic amide derivatives
US6399593B1 (en) 1999-05-04 2002-06-04 Wyeth Cyclic regimens using cyclic urea and cyclic amide derivatives
AR025457A1 (es) * 1999-08-31 2002-11-27 Schering Ag Mesoprogestinas (moduladores de receptores de progesterona) para el tratamiento y la prevencion de trastornos ginecologicos benignos hormona-dependientes
US8193252B1 (en) 1999-08-31 2012-06-05 Bayer Pharma AG Mesoprogestins (progesterone receptor modulators) for the treatment and prevention of benign hormone dependent gynecological disorders
UA73119C2 (en) * 2000-04-19 2005-06-15 American Home Products Corpoir Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors
EP1330257B1 (en) * 2000-10-30 2005-08-31 University Of Zurich Gnrh analogues for treatment of urinary incontinence
US6958142B2 (en) * 2002-08-02 2005-10-25 Balance Pharmaceuticals, Inc. Nasal spray formulation and method
US6960337B2 (en) * 2002-08-02 2005-11-01 Balance Pharmaceuticals, Inc. Methods and compositions for treating benign gynecological disorders
US7029657B2 (en) * 2002-08-02 2006-04-18 Balance Pharmaceuticals, Inc. Nasal spray steroid formulation and method
GB0302572D0 (en) 2003-02-05 2003-03-12 Astrazeneca Ab Method of treatment
US8257742B2 (en) * 2005-02-17 2012-09-04 Yissum Research Development Company Of The Hebrew University Of Jerusalem Bisphosphonates for treating endometriosis
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
US20060251581A1 (en) * 2005-05-09 2006-11-09 Mcintyre Jon T Method for treatment of uterine fibroid tumors
TWI455716B (zh) * 2006-10-24 2014-10-11 Repros Therapeutics Inc 選擇性黃體激素受體調節劑用於製造治療雌激素依賴性病症之藥物的用途
ES2643318T3 (es) * 2006-10-24 2017-11-22 Repros Therapeutics Inc. Composiciones y métodos para suprimir la proliferación endometrial
WO2008144143A1 (en) * 2007-05-14 2008-11-27 Drugtech Corporation Endometriosis treatment
JP5555631B2 (ja) * 2007-09-20 2014-07-23 ラピドット メディカル インポート アンド マーケティング リミテッド ミフェプリストンによる子宮平滑筋腫、平滑筋腫、筋腫、子宮類線維腫、子宮内膜症、または腺筋症を治療するための組成物および手段
RU2359684C1 (ru) * 2008-01-23 2009-06-27 Закрытое акционерное общество "СКАЙ ЛТД" Способ лечения эндометриоза
US9993427B2 (en) 2013-03-14 2018-06-12 Biorest Ltd. Liposome formulation and manufacture
EP3560555A1 (en) * 2018-04-26 2019-10-30 LifeArc A composition for treating one or more estrogen related diseases

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA8231B (en) 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
US4780461A (en) 1983-06-15 1988-10-25 Schering Aktiengesellschaft 13α-alkyl-gonanes, their production, and pharmaceutical preparations containing same
DE3347126A1 (de) 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen 11ss-aryl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
ES2054784T3 (es) 1987-08-08 1994-08-16 Akzo Nv Un metodo para la fabricacion de un implante.
DE3744054A1 (de) 1987-12-21 1989-06-29 Schering Ag Verwendung von antigestagenen zur herstellung von arzneimitteln
DE3921059A1 (de) 1989-06-23 1991-01-10 Schering Ag 11(beta)-aryl-4-estrene, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel
WO1991014704A2 (en) 1990-03-16 1991-10-03 Applied Research Systems Ars Holding N.V. Treatment of polycystic ovarian disease
US6827050B2 (en) 2001-12-21 2004-12-07 Caterpillar Inc Fluid control valve actuating system
US7283632B2 (en) 2003-09-09 2007-10-16 The Boeing Company Unauthorized access embedded software protection system

Also Published As

Publication number Publication date
NZ281441A (en) 1999-09-29
RO117420B1 (ro) 2002-03-29
BG100766A (bg) 1997-06-30
FI963036A0 (fi) 1996-08-01
FI963036A7 (fi) 1996-08-01
DE69509544D1 (de) 1999-06-10
LT96133A (en) 1997-01-27
SK96296A3 (en) 1997-07-09
FI963036L (fi) 1996-08-01
ES2132645T3 (es) 1999-08-16
PL315792A1 (en) 1996-12-09
LV11782A (lv) 1997-06-20
DK0785792T3 (da) 1999-10-18
CA2182183C (en) 2003-09-16
EP0785792B1 (en) 1999-05-06
LT4182B (en) 1997-06-25
AP9600840A0 (en) 1996-07-31
US5681817A (en) 1997-10-28
CZ291709B6 (cs) 2003-05-14
LV11782B (en) 1997-12-20
HU9601969D0 (en) 1996-09-30
CZ210396A3 (en) 1997-05-14
KR970700507A (ko) 1997-02-12
MD1432B2 (en) 2000-03-31
CN1144486A (zh) 1997-03-05
AP724A (en) 1999-01-18
EP0785792A1 (en) 1997-07-30
AU1838695A (en) 1995-08-21
MD1432C2 (ro) 2000-09-30
BG62238B1 (bg) 1999-06-30
WO1995020972A1 (en) 1995-08-10
DE69509544T2 (de) 1999-09-02
EP0785792A4 (OSRAM) 1997-07-30
CA2182183A1 (en) 1995-08-10
ATE179610T1 (de) 1999-05-15
PL178273B1 (pl) 2000-03-31
JP3130048B2 (ja) 2001-01-31
TJ242B (en) 1999-11-24
AU689229B2 (en) 1998-03-26
OA10777A (en) 2002-12-23
RU2110274C1 (ru) 1998-05-10
GR3030164T3 (en) 1999-08-31
JPH09508418A (ja) 1997-08-26
HUT74622A (en) 1997-01-28

Similar Documents

Publication Publication Date Title
FI963036A7 (fi) Munasarjan estrogeenista riippuvaisten tilojen hoito
FI935922L (fi) Menetelmä jäteveden käsittelemiseksi
NO995996L (no) Fremgangsmåte for behandling av fedme
NO20002172D0 (no) FremgangsmÕte for behandling av hyperkolesterolemi med usubstituert polydiallylamin
FI952060L (fi) Menetelmä atsitromysiinin annostamiseksi
FI973165L (fi) Menetelmä jäteveden aerobiseksi käsittelemiseksi
NO20010117D0 (no) Fremgangsmåte for behandling av sövnlöshet
DE69603089D1 (de) Zusammensetzung zur behandlung von mauerwerk
FI981853A0 (fi) Menetelmä ja laite taustahäiriön eliminoimiseksi
DE69301904D1 (de) Zusammensetzung zur behandlung von keratinfasern
DE69717846D1 (de) Behandlungsverfahren von laktamen
FI970244L (fi) Menetelmä vakiinnuttaa toonisen munasarjaestrogeenin erittyminen jatkettuja hoitotapoja varten
PT719499E (pt) Processo de tratamento anti-germinativo de tuberculos ou bolbos
DK0958115T3 (da) Fremgangsmåde til behandling af træ
DE69826913D1 (de) Verfahren zur Verringerung von Gleichkanalinterferenz
CS224391A3 (en) Method of treating allergic conjunctivitis
NO963237L (no) Behandling av ovariale östrogenavhengige tilstander
BR9507353A (pt) Método de tratar rinite alérgica
NO970118D0 (no) Forbindelse og fremgangsmåte for behandling av hårtap
NO20006382D0 (no) Fremgangsmåte for behandling av organofosfatforgiftning
FI943694A0 (fi) Menetelmä ja laite jätelipeän käsittelemiseksi
FI944083A7 (fi) Menetelmä ja laitteisto lietteen kuivaamiseksi
FI962750L (fi) Menetelmä neurogeenisen tulehduksen hoitamiseksi
FI961732A0 (fi) Menetelmä ja laitteisto neuloksen valmistukseen jaMenetelmä ja laitteisto neuloksen valmistukseen ja/tai käsittelyyn /tai käsittelyyn
NO970284L (no) Fremgangsmåte ved behandling av opportunistiske infeksjoner med azaspiraner

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal